These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1446957)

  • 21. Plasma heparin values and hemostasis in equids after subcutaneous administration of low-dose calcium heparin.
    Gerhards H; Eberhardt C
    Am J Vet Res; 1988 Jan; 49(1):13-8. PubMed ID: 3354959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged heparin administration during clopidogrel treatment in healthy subjects.
    Caplain H; D'Honneur G; Cariou R
    Semin Thromb Hemost; 1999; 25 Suppl 2():61-4. PubMed ID: 10440426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
    Eichinger S; Wolz M; Nieszpaur-Los M; Schneider B; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1994 Dec; 72(6):831-5. PubMed ID: 7740450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin for oral use: preliminary studies.
    Horwitz O; Johnson WT; Sayen JJ; Roberts B; Whereat AF
    Trans Am Clin Climatol Assoc; 1993; 104():94-102; discussion 102-3. PubMed ID: 1343451
    [No Abstract]   [Full Text] [Related]  

  • 26. [The efficacy of heparin chronotherapy in patients with chronic pyelonephritis].
    Agzamova RT; Zaslavskaia RM; Teĭblium MM; Perepelkin EG
    Ter Arkh; 1995; 67(6):54-7. PubMed ID: 7667784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of drug interaction between heparin and nitroglycerin. Randomized placebo-controlled crossover study.
    Bode V; Welzel D; Franz G; Polensky U
    Arch Intern Med; 1990 Oct; 150(10):2117-9. PubMed ID: 2121114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of morning or evening administration on absorption of theophylline.
    Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of minidoses of heparin on the blood coagulation and thrombocytic links of hemostasis in myocardial infarct in middle-aged and elderly patients].
    Nechaev DD; Bochko II; Kuz'mina LF; Martynov IV; Khloponina NN
    Ter Arkh; 1987; 59(10):105-8. PubMed ID: 3433205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro evidence of gender-related heparin resistance.
    Monte S; Lyons G
    Int J Obstet Anesth; 2004 Apr; 13(2):91-4. PubMed ID: 15321411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute lipidemic effect of calcium heparin in normolipemic and hyperlipemic subjects.
    Ferlito S; Ricceri M; Ossino AM
    Int Angiol; 1989; 8(3):140-4. PubMed ID: 2592796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin activity monitoring during vascular surgery.
    Jacobsen W; Brauer F; Smith LL
    Am J Surg; 1978 Jul; 136(1):141-4. PubMed ID: 677381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Indicators of blood coagulation and serum lipids after food loading and heparin administration].
    Malanowicz W; Zambrowicz K; Tenenbaum B
    Pol Arch Med Wewn; 1968; 40(5):591-8. PubMed ID: 5661499
    [No Abstract]   [Full Text] [Related]  

  • 36. [Heparin: chemico-pharmacological characteristics].
    Ferrari L; Boffi C
    Farmaco Prat; 1975 Oct; 30(10):461-77. PubMed ID: 1104374
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dose-response relations of N-formyl-chitosan-polysulfuric acid ester (Ro 1-8307) in regard to the activation of the clearing factor & inhibition of coagulation in comparison with heparin in animal experiments & in man].
    REBER K; STUDER A; TOBLER R; KOLLER F
    Acta Haematol; 1959 Jan; 21(1):31-5. PubMed ID: 13626505
    [No Abstract]   [Full Text] [Related]  

  • 38. Intrapulmonary heparin. A new procedure for anticoagulant therapy.
    Jaques LB; Mahadoo J; Kavanagh LW
    Lancet; 1976 Nov; 2(7996):1157-61. PubMed ID: 62993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preliminary studies of the blood clotting system following heparin administration in inhalations].
    Skarzyńska M
    Pol Arch Med Wewn; 1979 Oct; 62(4):315-20. PubMed ID: 503902
    [No Abstract]   [Full Text] [Related]  

  • 40. [Changes in hemostasis and vagal tonus in healthy individuals and patients with facial neuropathy by micro-dose heparin stimulation of nasal receptors].
    Uryvaev IV; Iudel'son IB; Sergeev VV
    Vestn Ross Akad Med Nauk; 1997; (8):22-3. PubMed ID: 9340043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.